About us

HCD was created out of an alliance with University of Chester, charities and health service sectors in reponse to the ever-growing demand for economic analysis within healthcare and specifically the need for health economics and business intelligence within the public and third sectors.

Through these partnerships, HCD provides a unique insight and perspective, focusing our analyses on what matters to patients as well as decision-makers, all undertaken with academic rigour, independence and credibility.

Continue Reading
Scroll for more

Our Process

We have created core partnerships with University of Chester and leading patient charities that underpin our approach.

Higher education

Academia has a leading role to play in providing an independent, credible evidence-base as well as evaluating current and new ways of delivering healthcare.


Our partnerships with patient charities ensure that any analyses we undertake reflect the day-to-day realities of living with a particular condition.


We apply primary or secondary real world data sources depending on research needs and questions. From ethically reviewed burden of illness studies and bespoke service primary data, to secondary sourced disease registries and episode statistics.

Scroll for more

Latest News

Check out what is happening at HCD Economics

May 2020

Practical Advice for researchers, undertaking studies out of the clinic

As part of a series of webinar’s developed to support the rare disease community, the World orphan drug congress (WCG), hosted part 6 in their series of COVID-19 webinars, on the subject of ‘Considerations When Moving Studies Out of the Clinic Setting’. The expert panel, David Borasky, Vice President of IRB Compliance for WCG, (WIRB-Copernicus Group) and Dawn Furey, Head of Portfolio Delivery Operations, The Janssen Pharmaceutical Companies of Johnson and Johnson and was moderated by Lyndsey McNair, Chief Medical Officer of WCG
Continue Reading
April 2020

The rare disease community convenes multiple webinars in response to COVID-19

During April there have been numerous webinars convened by and in support of the rare disease community. HCD Economics have been attending these events to raise internal level knowledge and developments across the various rare diseases currently being researched by the HCD teams. During May, HCD news will share reports on our news page, in a series entitled Rare Disease Community – COVID-19 update series. Detailed content from all April webinars will be published, to bring reports of the webinar content to our readers who may not have had the opportunity to attend them and for whom a summary plus guidance for further information will be a useful COVID-19/rare disease information resource.
Continue Reading
Scroll for more

Get in touch

...and one of our experts will get back to you ASAP.

Please be advised that we will not use your details for marketing purposes
Scroll for more